Tweets
Study of 100 pts w/ gouty arthritis, 51% had hypertension, nearly half insufficiently controlled. Undiagnosed HTN was seen in 18%. Gouty pts w/ HTN frequently (92%) had serum uric acid levels above the target https://t.co/jc0UGyrK2B https://t.co/kDD2KfQd3K
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Can SGLT2 Inhibitors Be Protective in Lupus and Vasculitis?
SGLT2 inhibitors are all the buzz in the renal world with reports of a renal protective and mortality lowering effects
https://t.co/9mzE06K9uO
#MedEd https://t.co/dVgOtCSHFU
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
86 #SLE pts w/ pulmonary embolism (age 38 yrs; avg lupus duration 46.5 mos) found 20% died; 1 yr (83.4%) & 3-year survival (79.4%). Mortality Predictors = Thrombocytopenia & lymphocytopenia. HCQ & anticoagulation were protective https://t.co/ot7H6LeLmu https://t.co/WdPgvOF8jJ
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Amitriptyline and FDA Treatments for Fibromyalgia #MedEd
https://t.co/9PylojjL4S https://t.co/TxErjtU4eE
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
It's our 8th year covering this important meeting! Join us June 1 - 4 for key opinion leader perspectives, clinical trial highlights and more, as we cover #EULAR2022. https://t.co/eHziBN3TWk
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Congratulations to Dr. Alexis Ogdie for being appointed Director of the Center for Clinical Epidemiology & Biostatistics at the Perelman School of Medicine at U Penn. CCEB is an interdisciplinary prg focused on research and educational thhttps://bit.ly/39N96Ok https://t.co/RlRCuYO7VV
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
May 2022 EMA meeting the CHMP recommended new indications for Cosentyx (juvenile PsA, Enthesitis-related arthritis), Olumiant (alopecia areata), Rinvoq (ulcerative colitis) and Xeljanz (ankylosing spondylitis). EMA approval pending https://t.co/KauDY6e8zS https://t.co/mmv4G9jHI7
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
NSAID use is not associated with increased COVID-19 severity, all-cause mortality, invasive ventilation, AKI, or ECMO in COVID-19 inpatients. 38-center retrospective cohort propensity matched of EHR data from the National COVID Cohort Collaborative. https://t.co/u6Id4WnLPT
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Disease modification has been defined in multiple disease areas but no widely accepted definition exists for SLE. Learn about the benefits & why there’s a need to consider therapies that modify the immunologic mechanisms of SLE. Sponsored by GSK USMA https://t.co/012Wk0d9Uu https://t.co/yteiuKDLLL
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
Study of 282 inflammatory arthritis (IA) pts Rx with TNFi, 11 (3/9%) had neutralizing anti-drug Abs (nADAb). nADAb+ was more likely in smokders; such had significantly worse Dz activity, physical function, & inflammatory markers https://t.co/TnEKGpTQ85 https://t.co/I0hv5X35P1
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
""It's easy to make a buck. It's a lot tougher to make a difference." - Tom Brokaw
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
NEJM Case: 73 yoM w/ 1 mo hx of fatigue & diffuse bone pain, pancytopenia (no abd pain, neuro Sx of HSM). WBC 1.7, Hgb 5.9, P111k, MRI shows AVN femura & Humerus. Bone marrow bx revealed macrophages w/ “wrinkled tissue paper” https://t.co/raObXpTHBr https://t.co/U6nQnPKtqI
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 2 months ago
